Immune priming and induction of tertiary lymphoid structures in a cord-blood humanized mouse model of gastrointestinal stromal tumor.

Saved in:
Bibliographic Details
Title: Immune priming and induction of tertiary lymphoid structures in a cord-blood humanized mouse model of gastrointestinal stromal tumor.
Authors: He B; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Western Australia, Australia., Dymond L; Translational Cancer Research Program, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Western Australia, Australia., Wood KH; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Western Australia, Australia., Bastow ER; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Western Australia, Australia., Satiaputra J; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Western Australia, Australia., Li J; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Western Australia, Australia., Johansson-Percival A; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Western Australia, Australia., Hamzah J; Imaging & Therapy Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Western Australia, Australia., Kumarasinghe MP; Department of Anatomical Pathology, PathWest QEII Medical Centre, Perth, Western Australia., Ballal M; Department of General Surgery, Fiona Stanley Hospital, Western Australia, Australia.; Division of Surgery, School of Medicine, University of Western Australia, Western Australia, Australia., Foo J; Division of Surgery, School of Medicine, University of Western Australia, Western Australia, Australia.; Sir Charles Gairdner Hospital, QEII Medical Centre, Perth, Western Australia, Australia., Johansson M; Sir Charles Gairdner Hospital, QEII Medical Centre, Perth, Western Australia, Australia., Ee HC; Sir Charles Gairdner Hospital, QEII Medical Centre, Perth, Western Australia, Australia.; Division of Internal Medicine, School of Medicine, University of Western Australia, Western Australia, Australia., White SW; Division of Obstetrics and Gynaecology, Faculty of Medicine, Dentistry, and Health Sciences, The University of Western Australia, Perth, Western Australia, Australia., Winteringham L; Translational Cancer Research Program, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Western Australia, Australia., Ganss R; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Western Australia, Australia.; Translational Cancer Research Program, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Western Australia, Australia.
Source: Oncoimmunology [Oncoimmunology] 2024 Sep 22; Vol. 13 (1), pp. 2406576. Date of Electronic Publication: 2024 Sep 22 (Print Publication: 2024).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2162-402X
DOI:10.1080/2162402X.2024.2406576